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Humoral immune responses initiate in the lymph node draining the site of viral infection
(dLN). Some viruses subvert LN B cell activation; however, our knowledge of viral hindrance
of B cell responses of important human pathogens is lacking. Here, we define mechanisms
whereby chikungunya virus (CHIKV), a mosquito-transmitted RNA virus that causes out-
breaks of acute and chronic arthritis in humans, hinders dLN antiviral B cell responses.
Infection of WT mice with pathogenic, but not acutely cleared CHIKV, induced MyD88-
dependent recruitment of monocytes and neutrophils to the dLN. Blocking this influx im-
proved lymphocyte accumulation, dLN organization, and CHIKV-specific B cell responses.
Both inducible nitric oxide synthase (iNOS) and the phagocyte NADPH oxidase (Nox2) con-
tributed to impaired dLN organization and function. Infiltrating monocytes expressed iNOS
through a local IRF5- and IFNAR1-dependent pathway that was partially TLR7-dependent.
Together, our data suggest that pathogenic CHIKV triggers the influx and activation of
monocytes and neutrophils in the dLN that impairs virus-specific B cell responses.
Author summary
Elucidating mechanisms by which viruses subvert B cell immunity and establish persistent
infection is essential for the development of new therapeutic strategies against chronic
viral infections. The humoral immune response initiates in the lymph node draining the
site of viral infection. However, how persistent viruses evade B cell responses is poorly
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understood. In this study, we find that infection with pathogenic, persistent chikungunya
virus triggers rapid recruitment of neutrophils and monocytes to the draining lymph
node, which impair structural organization, lymphocyte accumulation, and downstream
virus-specific B cell responses that are important for control of infection. This work
enhances our understanding of the pathogenesis of acute and chronic CHIKV disease and
highlights how local innate immune responses in draining lymphoid tissue dictate the
effectiveness of downstream adaptive immunity.
Introduction
Draining lymphoid organs have a critical role in the initiation of effective adaptive immune
responses to vaccines and pathogens. B cells and virus-specific antibodies (Abs) are important
arms of the adaptive immune response for limiting viral dissemination and controlling viral
infections. The antiviral Ab response is initiated in the draining lymph node (dLN) through a
series of molecular interactions and cellular movements that require intact lymphoid tissue
architecture and function. Naïve B cells enter the dLN through high endothelial venules
(HEVs) and then migrate to defined follicles subjacent to the dLN subcapsular sinus (SCS) [1].
B cells acquire viral antigen through interactions with SCS macrophages which readily acquire
viral antigens borne by the afferent lymphatics [2]. After activation, B cells migrate to the bor-
ders of the B cell follicle and to the interfollicular region of the dLN to encounter CD4+ T cells.
Some of these activated, proliferating B cells go on to form plasmablasts, while others persist in
tight clusters in the follicle, forming germinal centers (GCs) [3, 4].
Some viruses have evolved strategies to subvert humoral immune responses in the dLN.
Lymphocytic choriomeningitis virus (LCMV), a prototypical mouse pathogen, impairs Ab
responses in the dLN via a number of mechanisms, including the recruitment of inflammatory
monocytes that promote B cell apoptosis [5]. Vaccinia virus disrupts the dLN SCS macrophage
layer, preventing antigen acquisition and subsequent B cell responses [6]. In humans, HIV
infection of CD4+ T cells results in loss of follicular T helper cell responses and impaired Ab
production [7].
Arthritogenic alphaviruses, including chikungunya virus (CHIKV), Mayaro virus, and Ross
River virus, are emerging public health concerns. CHIKV, in particular, re-emerged in 2004 to
cause massive outbreaks of disease affecting millions [8]. Acute CHIKV disease presents with
rapid onset of fever and rash, with severe joint swelling and arthralgia. A high proportion of
individuals develop chronic arthralgia or arthritis that lasts for months to years after initial
infection [9]. Following CHIKV infection, the humoral response reduces acute disease severity
and controls viremia [10], and passive transfer of immune serum or monoclonal antibodies
protects from fatal CHIKV disease [11–13]. However, B cells and Ab are unable to mediate
complete clearance of CHIKV from all sites of infection [14–22]. Thus, chronic CHIKV dis-
ease in musculoskeletal tissue may be driven by failure of the adaptive immune response to
prevent or control viral persistence.
Clearance of the attenuated CHIKV strain 181/25 from musculoskeletal tissue depends on
virus-specific Ab production. In comparison, pathogenic CHIKV strains persist in joint-asso-
ciated tissue of immunocompetent mice [14, 15], suggesting that the development of virus-
specific B cell responses may be impaired during CHIKV infection. Indeed, we previously
found that pathogenic CHIKV strains disable immune responses in the dLN of infected mice
by impairing naïve lymphocyte entry and expansion of HEVs [23]. Additionally, the dLN
exhibited follicular disorganization, with a loss of the B-T cell border and poor GC formation
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following pathogenic CHIKV infection. However, the mechanisms leading to architectural dis-
ruption and impaired lymphocyte accumulation remained to be defined.
In this study, we find that a MyD88-dependent influx of monocytes and neutrophils to the
dLN disrupts structural organization, impairs lymphocyte accumulation, and diminishes
downstream antiviral B cell responses to pathogenic CHIKV infection in a manner partially
dependent on expression of inducible nitric oxide synthase (iNOS) and the phagocyte
NADPH oxidase (Nox2). We also identify a role for local IRF5-driven type I IFN signaling in
the dLN that is triggered by TLR7 and one or more additional TLR(s) and promotes iNOS
expression in infiltrating monocytes. Overall, our data suggest that the rapid, early influx of
monocytes and neutrophils detrimentally impacts the B cell response to pathogenic CHIKV
infection through a novel IRF5-dependent mechanism.
Results
Pathogenic CHIKV infection triggers recruitment of monocytes and
neutrophils to the dLN
In previous studies, we found that infection of mice with the attenuated and acutely cleared
CHIKV strain 181/25 [14, 24] resulted in dLN hypertrophy, accumulation of lymphocytes, and
formation of GCs [23], all hallmarks of appropriate innate and adaptive immune responses to
the infection. In contrast, the dLN of mice infected with pathogenic, persistent CHIKV strains
became highly disorganized as early as 3 days post-infection (dpi), and failed to accumulate
lymphocytes or develop GCs due in part to disruption of HEV-mediated lymphocyte recruit-
ment [23]. Consistent with the robust response of the dLN to attenuated 181/25 infection, the
presence of LNs is essential for clearance of 181/25 infection from joint-associated tissue (S1
Fig). To elucidate the mechanisms that lead to the rapid disorganization and function of the
dLN following pathogenic CHIKV infection, we characterized cell populations at early times
post-infection with pathogenic (parental strain AF15561) or attenuated (derivative strain 181/
25) CHIKV, which differ by only five amino acids across the genome [25]. Pathogenic, but not
attenuated CHIKV infection, resulted in increased numbers of monocytes (CD11b+Ly6Chi-
Ly6G-) and neutrophils (CD11bhiLy6C+Ly6G+) in the blood and dLN within 24 h of infection
(S2A–S2C Fig and Fig 1A–1C). The influx of monocytes and neutrophils into the dLN pre-
ceded their arrival in the foot, the site of virus inoculation (S2D–S2F Fig), which occurs
between 3 and 5 dpi [26]. In contrast, few monocytes and neutrophils were present in the
dLNs of mock-infected mice or mice inoculated with the attenuated CHIKV strain (Fig 1D).
Consistent with our flow cytometric analysis, immunofluorescence staining of dLN sections at
1 dpi detected a large population of Gr-1+ monocytes and neutrophils in the dLNs of mice
infected with pathogenic CHIKV. These cells were mostly localized within the SCS and medul-
lary sinuses, with a smaller population of monocytes and neutrophils within the B cell follicles
(Fig 1D). Thus, during pathogenic, but not attenuated, CHIKV infection, a rapid influx of
monocytes and neutrophils into the dLN precedes its extensive disorganization.
Monocyte and neutrophil influx causes reduced lymphocyte accumulation
and dLN disorganization
Pathogenic CHIKV infection results in decreased accumulation of naïve lymphocytes and
extensive lymphocyte relocalization in the dLN [23]. Because monocyte and neutrophil infil-
tration of the dLN preceded the disruption of lymphocyte populations (Fig 1 and [23]), we
hypothesized that accumulation of myeloid cells in the dLN might disrupt its architecture. To
prevent the early influx of monocytes and neutrophils into the dLN, we treated mice with a
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single dose of anti-Gr-1 monoclonal antibody (mAb) the day before inoculation with patho-
genic CHIKV, which effectively depleted monocytes and neutrophils from the circulation (Fig
2A–2C) and the dLN (Fig 2D–2F). Remarkably, a single anti-Gr-1 mAb treatment prior to
pathogenic CHIKV infection restored total cell numbers at 5 dpi in the dLN to levels nearly
equivalent to those detected during acutely cleared CHIKV infection (Fig 2G), an effect that
was due principally to changes in B and CD4+ T cell numbers (Fig 2H and 2I). CD8+ T cell
numbers in anti-Gr-1-treated mice remained lower than in mice infected with the attenuated
CHIKV strain (Fig 2J). The failure to fully restore CD8+ T cell numbers may reflect some effect
of the anti-Gr-1 mAb on CD8+ T cells, some of which express Gr-1 upon activation [27].
Depletion of monocytes and neutrophils prior to attenuated CHIKV infection did not affect
total cell numbers in the dLN at 5 dpi (S3 Fig).
Pathogenic CHIKV infection causes marked disorganization of lymphocyte populations
within the dLN [23], with paracortical relocalization of B cells, diffuse positioning of CD8+ T
cells, and loss of a well-defined B-T cell border by 5 dpi. In mice treated with anti-Gr-1 mAb
prior to pathogenic CHIKV infection, we observed improved follicular organization and a
defined B-T cell border compared with the isotype control group (Fig 2K). Together, these
data suggest that the early influx of monocytes and neutrophils into the dLN following
Fig 1. Myeloid cells infiltrate the dLN early after pathogenic CHIKV infection. C57BL/6 mice were inoculated with PBS (mock) or 103 plaque forming units
(PFU) of CHIKV 181/25 or AF15561 in the left footpad, and the dLN was analyzed at 24 hpi. (A) Representative flow cytometry plots and numbers of (B)
CD11b+Ly6Chi monocytes or (C) CD11bhiLy6C+Ly6G+ neutrophils in the dLN. (D) Frozen dLN sections were stained for ERTR7+ stromal cells (red), B220+ B cells
(blue), or Gr-1+ monocytes and neutrophils (white). Errors bars represent mean ± SEM. Data are combined from or representative of 5 (A-C) or 2 (D) independent
experiments (n = 15–21 (A-C) or 2–3 (D) mice per group). Statistical significance was determined by one-way ANOVA with Tukey’s post-test (�, P< 0.05; ���,
P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g001
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Fig 2. Delaying the early influx of myeloid cells to the dLN prevents lymphocyte depletion and restores dLN architecture. C57BL/6 mice
were left untreated or treated with 300–500 μg of IgG2b isotype control mAb or anti-Gr-1 mAb via intraperitoneal injection one day prior to
inoculation with 103 PFU of CHIKV 181/25 or AF15561 in the left footpad. (A) Representative flow cytometry plots and percentages of (B)
CD11b+Ly6Chi monocytes or (C) CD11bhiLy6C+Ly6G+ neutrophils in the blood. (D) Representative flow cytometry plots and numbers of (E)
CD11b+Ly6Chi monocytes or (F) CD11bhiLy6C+Ly6G+ neutrophils in the dLN. Data are combined from two independent experiments (n = 3
(mock) to 7 per group). At 5 dpi, the dLN was analyzed for (G) total cells, (H) CD19+B220+ B cells, (I) TCRβ+CD4+ T cells, and (J)
TCRβ+CD8+ T cells. Data are combined from 3 independent experiments (n = 4 (mock) or 11 per group). (K) Frozen dLN sections were
stained for ERTR7+ stromal cells (red), B220+ B cells (blue), or CD8+ T cells (green). Errors bars represent mean ± SEM. Data in (G-J) are
Monocytes and neutrophils impair CHIKV B cell responses
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pathogenic CHIKV infection results in both impaired lymphocyte accumulation and altered
lymphocyte localization.
To evaluate which specific Gr-1+ cell type, monocytes or neutrophils, was responsible for
the defect in lymphocyte accumulation in the dLN following pathogenic CHIKV infection, we
treated mice with an anti-Ly6G mAb to deplete neutrophils alone or an anti-CCR2 mAb [28]
to deplete Ly6Chi monocytes alone. In each case, either neutrophils (Fig 3A and 3B) or mono-
cytes (Fig 3G and 3H) were specifically depleted from the circulation and the dLN. As we did
not observe restoration of dLN total cell numbers at 5 dpi in mice depleted of either neutro-
phils (Fig 3A–3F) or Ly6Chi monocytes (Fig 3G–3L), the influx of either cell type likely can
prevent lymphocyte accumulation in the dLN.
Early monocyte and neutrophil influx into the dLN inhibits subsequent GC
formation and neutralizing Ab responses
In comparison with attenuated CHIKV infection, pathogenic CHIKV infection induces poor
GC formation in the dLN and a diminished neutralizing serum Ab response [14, 23]. We
hypothesized that the enhanced lymphocyte accumulation and organization in the dLN of
mice depleted of monocytes and neutrophils prior to pathogenic infection would improve GC
formation. To investigate this idea, mice were treated with a single dose of anti-Gr-1 or isotype
control mAb one day prior to pathogenic CHIKV infection, and GC responses in the dLN
were evaluated at 14 dpi by staining sections with the GC B cell marker GL7. Anti-Gr-1 mAb-
treated mice had increased numbers of GCs per dLN, and the GCs were larger than those of
the isotype control group (Fig 4A–4C), resulting in an increased total GC area in the dLN (Fig
4D). Flow cytometry analysis also showed an increased percentage and number of
CD95+GL7+ GC B cells in the dLN of mice infected with pathogenic CHIKV and treated with
anti-Gr-1 mAb (Fig 4E–4G). Early depletion of monocytes and neutrophils also resulted in
greater numbers of CD138+IgDlo plasma cells (PCs) (Fig 4H–4J) and increased the number of
CHIKV-specific Ab-secreting cells (ASCs) in the dLN (Fig 4K). The effects of anti-Gr-1 mAb
treatment were most pronounced in the dLN, as we observed modest effects on the percent-
ages of GC B cells and plasma cells in the left inguinal LN and the spleen (S4 Fig). Anti-Gr-1
mAb treatment had no effect on the amount of total CHIKV-specific IgG present in serum at
day 7, 14, and 28 dpi (Fig 4L). However, consistent with the effects of anti-Gr-1 mAb treat-
ment on GC formation, we observed an increase in CHIKV neutralization activity in the
serum of anti-Gr-1-treated mice compared with the isotype control group at 28 dpi (Fig 4M).
Together, these data demonstrate that early depletion of monocytes and neutrophils during
pathogenic CHIKV infection improves the endogenous, polyclonal virus-specific GC B cell
responses in the dLN and, despite predominantly impacting the dLN, leads to a modest but
detectable improvement in serum Ab neutralization activity.
Mechanisms of pathogenic CHIKV-induced monocyte and neutrophil
recruitment
We next investigated the molecular pathways by which monocytes and neutrophils are
recruited into the dLN following pathogenic CHIKV infection. Recruitment of Ly6Chi mono-
cytes to inflamed tissue or the dLN in response to viral infection is reportedly CCR2- and type
I IFN-dependent [5, 29]. Accordingly, we first investigated the role of type I IFN signaling in
combined from 3 independent experiments. Data in (K) are representative of 2 independent experiments with 4–5 LNs per group. Statistical
significance was determined by one-way ANOVA with Tukey’s post-test (�, P< 0.05; ��, P< 0.01; ���, P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g002
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Fig 3. Monocytes or neutrophils prevent lymphocyte accumulation in the dLN during pathogenic CHIKV infection. (A-F) C57BL/6 mice
were treated with 300 μg of IgG2a isotype control Ab or anti-Ly6G mAb via intraperitoneal injection one day prior to inoculation with 103
Monocytes and neutrophils impair CHIKV B cell responses
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the accumulation of monocytes and neutrophils in the dLN following pathogenic CHIKV
infection. As shown in Fig 5A, the total number of dLN cells following pathogenic CHIKV
infection was reduced in Ifnar1-/- compared with wild-type (WT) mice; type I IFN signaling
normally inhibits lymphocyte egress [30], but this does not occur in mice lacking the type I
IFN receptor and likely contributes to the reduced cell numbers. The percentage of neutrophils
was increased in the dLN of Ifnar1-/- mice compared with WT mice after pathogenic CHIKV
infection (Fig 5B and 5C), which resulted in a similar total number of neutrophils in the dLN
of WT and Ifnar1-/- mice (Fig 5D) despite the overall decrease in total number of dLN cells.
The frequencies of Ly6Chi monocytes were similar in the dLN of CHIKV-infected WT and
Ifnar1-/- mice (Fig 5E) although the total number of monocytes in the dLN was reduced in
Ifnar1-/- mice.
Because TLR ligands can promote monocyte egress from the bone marrow to sites of infec-
tion [31], we evaluated neutrophil and monocyte recruitment to the dLN of mice deficient in
MyD88, the canonical adaptor for many TLRs and the interleukin-1 receptor (IL-1R) family
[32]. Genetic deletion of MyD88 had minimal impact on the total number of cells in the dLN
at 24 hpi (Fig 5G). However, MyD88-dependent signals were required for and contributed to
neutrophil (Fig 5H–5J) and monocyte (Fig 5H, 5K and 5L) recruitment, respectively, to the
dLN following pathogenic CHIKV infection. Mice treated with anti-IL-1R blocking mAb at
the time of infection showed no change in total cells in the dLN compared with control IgG-
treated mice (Fig 5M), but had reduced neutrophils (percentage and total number; Fig 5N–
5P), indicating that the MyD88-IL-1R signaling axis regulates the rapid accumulation of neu-
trophils in the dLN during pathogenic CHIKV infection. In contrast, the percentage and total
number of monocytes were unchanged in the anti-IL-1R-treated group compared with the
IgG-treated group (Fig 5N, 5Q and 5R). Together, these data demonstrate that in response to
pathogenic CHIKV infection 1) type I IFN signaling inhibits and IL-1R signaling promotes,
neutrophil recruitment to the dLN, and 2) IL-1R-independent, MyD88-dependent signal(s)
promote the recruitment of monocytes to the dLN.
Nos2 and Nox2 contribute to reduced lymphocyte numbers and
disorganization in the dLN
Myeloid cells can suppress immune responses by a variety of mechanisms, including through
the production of nitric oxide (NO) via the action of inducible nitric oxide synthase (iNOS,
encoded by Nos2) [33]. Moreover, superoxide derived from the activity of the phagocyte
NADPH oxidase (NOX2, encoded by gp91phox, also known as Cybb) can combine with NO to
form the reactive nitrogen species peroxynitrite (ONOO-), which also can suppress immune
responses [34, 35]. Based on this knowledge, we hypothesized that monocytes and neutrophils
infiltrating the dLN disrupt lymphocyte accumulation and tissue organization through the
actions of iNOS and NOX2. Consistent with the lack of effect of monocyte and neutrophil
depletion on accumulation of lymphocytes in the dLN following attenuated CHIKV infection
(S3 Fig), total cell numbers in the dLN were unchanged in Nos2-/- and Nox2-/- mice infected
PFU of CHIKV AF15561 in the left footpad. Representative flow cytometry plots of CD11b+Ly6Chi monocytes or CD11bhiLy6C+Ly6G+
neutrophils in the (A) blood or (B) dLN. At 5 dpi, the dLN was analyzed for (C) total cells, (D) CD19+B220+ B cells, (E) TCRβ+CD4+ T cells,
and (F) TCRβ+CD8+ T cells. (G-L) C57BL/6 mice were treated with 50 μg of IgG2b isotype control mAb or anti-CCR2 mAb via
intraperitoneal injection one day prior to inoculation with 103 PFU of CHIKV AF15561 in the left footpad. Representative flow cytometry
plots of CD11b+Ly6Chi monocytes or CD11bhiLy6C+Ly6G+ neutrophils in the (G) blood or (H) dLN. At 5 dpi, the dLN was analyzed for (I)
total cells, (J) CD19+B220+ B cells, (K) TCRβ+CD4+ T cells, and (L) TCRβ+CD8+ T cells. Errors bars represent mean ± SEM. Data are
combined from two independent experiments (n = 6–9 per group). Statistical significance was determined by Student’s t-test (n.s., not
significant).
https://doi.org/10.1371/journal.ppat.1008292.g003
Monocytes and neutrophils impair CHIKV B cell responses
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008292 January 30, 2020 8 / 25
Fig 4. Depletion of myeloid cells improves dLN B cell responses. C57BL/6 mice were treated with 300–500 μg IgG2b isotype control
mAb or anti-Gr-1 mAb via intraperitoneal injection one day prior to inoculation with 103 PFU of CHIKV AF15561 in the left footpad.
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with attenuated CHIKV (Fig 6A). However, total cell numbers in the dLN were partially
restored in Nos2-/- and Nox2-/- mice inoculated with pathogenic CHIKV compared with WT
mice (Fig 6A), suggesting that NO and superoxide contribute to reduced lymphocyte numbers
in the dLN during pathogenic CHIKV infection. In addition to partial restoration of lympho-
cyte numbers, the dLNs of Nos2-/- and Nox2-/- mice infected with pathogenic CHIKV showed
improved follicular and paracortical organization, and a more clearly defined B-T cell border
compared with the dLN of WT mice (Fig 6B). These data suggest that both Nos2 and Nox2
contribute to the disruption of lymphocyte organization that occurs during pathogenic
CHIKV infection.
(A) At 14 dpi, dLN sections were stained for ERTR7+ stromal cells, B220+ B cells, and GL7+ GC B cells. (B) Area per GC, (C) Number of
GCs per LN section, and (D) total GC area per LN were determined. (E) Representative flow cytometry plots of GL7+CD95+ GC B cells
(gated on CD19+B220+ cells), (F) percentage and (G) total number of GC B cells in the dLN at 14 dpi. (H) Representative flow
cytometry plots of CD138+IgD- plasma cells (gated on CD19+), (I) percentage and (J) total number of plasma cells in the dLN at 14 dpi.
(K) Number of CHIKV-specific IgG+ antibody secreting cells (ASCs) in the dLN at 14 dpi. Serum collected at the indicated timepoints
was assayed for (L) total CHIKV-specific IgG by ELISA (expressed as fold change in IgG endpoint over the IgG2b group) and (M)
neutralizing activity of CHIKV by focus reduction neutralization test (FRNT, expressed as fold change in FRNT50 over the IgG2b
group). Errors bars represent mean ± SEM. Data in (A-D) are derived from 5–6 LNs per group with 7–12 LN sections analyzed per
group. Data in (E-M) are derived from 2–3 independent experiments with 7–10 mice per group. Statistical significance was determined
by Student’s t-test in B-D (note that significance is only displayed for comparison of IgG2b and α-Gr-1 groups), F-G, I-J, and K; or by
two-way ANOVA with Bonferroni’s post-test in L-M (�, P< 0.05; ��, P< 0.01; ���, P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g004
Fig 5. Mechanisms of pathogenic CHIKV-induced myeloid cell recruitment to the dLN. Mice were inoculated with 103 PFU of CHIKV AF15561 in the left footpad. At
24 hpi, total cells, CD11bhiLy6C+Ly6G+ neutrophils, and CD11b+Ly6Chi monocytes in the dLN were enumerated in (A-F) WT or Ifnar1-/- mice, (G-L) WT or Myd88-/-
mice, or (M-R) WT mice treated with 200 μg IgG or α-IL-1R Ab at the time of infection. Errors bars represent mean ± SEM. Data are combined from 2–4 independent
experiments (n = 7–16 mice per group). Statistical significance was determined by Student’s t-test (�, P< 0.05; ���, P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g005
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Fig 6. Nos2 and Nox2 contribute to disrupted dLN architecture and lymphocyte depletion. WT, Nos2-/-, or Nox2-/- (gp91phox-/-) mice were
inoculated with PBS or 103 PFU of CHIKV AF15561 in the left footpad. (A) At 5 dpi, total cells in the dLN were enumerated. Data are
Monocytes and neutrophils impair CHIKV B cell responses
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The partial restoration of cell numbers and markedly improved lymphocyte organization in
the dLN were not due to a difference in early monocyte and neutrophil infiltration or localiza-
tion at 24 hpi between WT, Nos2-/-, and Nox2-/- mice (Fig 6C–6F). To define the iNOS-
expressing cell type(s) that mediate the Nos2-dependent effects on dLN cell numbers and orga-
nization, we analyzed cell populations in the dLN at 24 hpi by flow cytometry. Monocytes elic-
ited by pathogenic CHIKV infection expressed iNOS in the dLN, but not in the blood (Fig 6G
and 6H). iNOS staining was absent in neutrophils in the dLN (Fig 6G), and was absent in
Nos2-/- mice, as expected (Fig 6G). Together, these data indicate that expression of Nos2 and
Nox2 contribute to impaired lymphocyte accumulation and dLN disorganization, and that
monocytes upregulate iNOS expression following entry into the dLN.
iNOS expression in monocytes is driven by an IFNAR1- and
IRF5-dependent pathway
We next evaluated the molecular pathways that promote iNOS expression in monocytes infil-
trating the dLN. Many inflammatory stimuli can induce iNOS expression, including type I
IFNs [36]. Indeed, type I IFN receptor signaling was required for expression of iNOS in dLN
monocytes following CHIKV infection (Fig 7A and 7B). Type I IFN signaling and either IRF3
or IRF7 are required for protection from fatal CHIKV infection, with IRF7 responsible for sys-
temic type I IFN production [37, 38]. Unexpectedly, both IRF3 and IRF7 were dispensable for
iNOS induction in dLN monocytes (Fig 7A and 7B). Instead, Irf3-/-Irf5-/-Irf7-/- triple knockout
mice showed diminished monocyte iNOS expression similar to that of Ifnar1-/- mice, suggest-
ing a requirement for IRF5. The dependency on IRF5 for monocyte iNOS expression was con-
firmed in Irf5-/- mice (Fig 7C and 7D). Together, these data suggest that IRF5- and
IFNAR1-dependent signals act locally in the dLN to induce iNOS expression in infiltrating
monocytes during pathogenic CHIKV infection.
iNOS expression in monocytes requires MyD88 and is partially dependent
on TLR7
We next assessed the upstream signals required for monocyte expression of iNOS. IRF5 can be
activated in a MyD88-dependent manner by TLR7 or TLR9 agonists [39–41]. In the context of
some inflammatory stimuli, TLR3-mediated TRIF signaling can synergize with MyD88 for full
IRF5 activation [42, 43]. However, pathogenic CHIKV-induced iNOS expression in dLN
monocytes was independent of TRIF (S5A and S5B Fig). Instead, iNOS expression in infiltrat-
ing monocytes was completely dependent on MyD88 (Fig 7E and 7F), and partially dependent
on TLR7 (Fig 7E and 7F), suggesting that multiple MyD88-dependent signals contribute to
IRF5 activation. To determine whether the other MyD88-dependent signal responsible for
iNOS induction originated from IL-1R, we treated mice with an IL-1R blocking mAb at the
time of infection. IL-1R blockade did not alter the percentage of iNOS-expressing monocytes
in the dLN (Fig 7G and 7H). Together, these data suggest that TLR7 and one or more
combined from 3–4 independent experiments (n = 4–16 mice per group). (B) Frozen dLN sections (6–7 LNs per group) were stained for
ERTR7+ stromal cells (red), B220+ B cells (blue), or CD8+ T cells (green). (C) At 24 hpi, representative flow cytometry plots and numbers of
(D) CD11b+Ly6Chi monocytes or (E) CD11bhiLy6C+Ly6G+ neutrophils in the dLN. (F) Frozen dLN sections were stained for B220+ B cells
(blue), or Gr-1+ monocytes and neutrophils (white). (G) Representative flow cytometry plots and (H) numbers of iNOS+ cells among
circulating (bottom) or dLN (top) CD11b+Ly6Chi monocytes in WT and Nos2-/- mice. Errors bars represent mean ± SEM. Data are combined
from (A, C-E, G-H) or representative of (B, F) 2–3 independent experiments (n = 4–12 mice per group). Statistical significance in (A–
displayed only for comparison between AF15561-infected groups) and (H) was determined by Student’s t-test to compare groups (���,
P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g006
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Fig 7. Mechanisms of iNOS expression in monocytes recruited to the dLN. Mice were inoculated with PBS (mock) or 103 PFU of CHIKV AF15561 in the left
footpad, and the dLN was analyzed at 24 hpi. (A) Representative flow cytometry plots and (B) percentage of CD11b+Ly6Chi monocytes expressing iNOS in WT,
Ifnar1-/-, Irf3-/-Irf7-/-, or Irf3-/-Irf5-/-Irf7-/- mice. (C) Representative flow cytometry plots and (D) percentage of CD11b+Ly6Chi monocytes expressing iNOS in WT or
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additional MyD88-dependent TLRs activate IRF5 to drive iNOS expression in dLN infiltrating
monocytes following pathogenic CHIKV infection.
An IRF5-dependent pathway is activated locally in the dLN
The upregulation of iNOS in monocytes in the dLN, but not in circulation, and the require-
ment for IFNAR1 and IRF5 in this induction suggested the presence of an IRF5-dependent
type I IFN pathway acting locally in the dLN. To investigate this idea, we infected WT,
Irf3-/-Irf7-/-, and Irf3-/-Irf5-/-Irf7-/- mice with pathogenic CHIKV. At 24 hpi, we measured the
induction of interferon stimulated genes (ISGs) including Ccl2, Cxcl10, Ifng, Il6, Ifit1, and
Rsad2 mRNA [44, 45] in the inoculated foot and in the dLN by quantitative reverse transcrip-
tion polymerase chain reaction (qRT-PCR). Each of these ISGs was upregulated in both the
foot and dLN of CHIKV-infected WT mice at this timepoint (Fig 8A–8F). However, up-
regulation was differentially dependent on IRF3/IRF7 or IRF5 in each tissue. In the inoculated
foot, upregulation of all ISGs analyzed was dependent on IRF3/IRF7 (Fig 8A–8F). However,
in the dLN, the induction of Ccl2, Cxc10, Ifng, and Il6 mRNA was similar between WT and
Irf3-/-Irf7-/- mice (Fig 8A–D), whereas Ifit1 and Rsad2 upregulation in the dLN were only par-
tially dependent on the presence of IRF3/IRF7 (Fig 8E and 8F). Instead, for each ISG, the com-
bined deficiency of IRF3, IRF5, and IRF7 resulted in reduced upregulation in the dLN
compared with WT or Irf3-/-Irf7-/- mice (Fig 8A–8F). Together, these data demonstrate that
induction of multiple ISGs at the site of inoculation is dependent on IRF3/IRF7, whereas an
IRF5-dependent ISG induction pathway is activated in the dLN.
Discussion
Our results demonstrate that a rapid influx of Ly6Chi monocytes and neutrophils into the dLN
triggered by infection with pathogenic, persistent strains of CHIKV reduces the accumulation
of lymphocytes, disrupts lymphocyte organization, and impairs the development of virus-spe-
cific B cell responses. Preventing the early influx of Ly6Chi monocytes and neutrophils into the
dLN improved accumulation of lymphocytes and follicular organization and enhanced dLN
GC formation, plasma cell differentiation, and CHIKV-specific serum neutralizing antibody
responses. Lymphocyte accumulation and dLN organization was improved in CHIKV-
infected mice lacking Nos2 (iNOS) or the phagocyte NADPH oxidase Nox2. Monocytes, but
not other cell types, upregulated iNOS following entry into the dLN in a manner dependent
on IFNAR1, IRF5, and MyD88, and partially dependent on TLR7. Although IRF3/IRF7-de-
pendent type I IFN production is required for protection from fatal CHIKV infection [37, 46],
we identified an IRF5-dependent pathway acting locally within the dLN following pathogenic
CHIKV infection that drives activation of infiltrating monocytes.
Following infection or vaccination, innate immune cells are recruited to lymphoid tissues
[5, 47–49]. Myeloid-derived cells can have suppressive effects on adaptive immunity, depend-
ing on the local inflammatory milieu. For example, monocytes recruited to the dLN of LCMV-
infected mice co-localize with and deplete virus-specific B cells in the interfollicular area [5].
Here, we show that pathogenic, but not acutely cleared CHIKV, similarly induces rapid
recruitment of monocytes and neutrophils to the dLN. During pathogenic CHIKV infection,
recruited monocytes and neutrophils localized to the SCS and medullary sinuses, with some
Irf5-/- mice. (E) Representative flow cytometry plots and (F) percentage of CD11b+Ly6Chi monocytes expressing iNOS in WT, Tlr7-/-, or Myd88-/- mice. (G-H) WT mice
were treated with 200 μg of IgG or α-IL-1R Ab at the time of infection. (G) Representative flow cytometry plots and (H) percentage of CD11b+Ly6Chi monocytes
expressing iNOS. Errors bars represent mean ± SEM. Data are combined from 2–3 independent experiments. Statistical significance is displayed only for comparison
between infected groups (mock not included) and was determined by one-way ANOVA with Tukey’s post-test (B, F) or Student’s t-test (D, H) (���, P< 0.001).
https://doi.org/10.1371/journal.ppat.1008292.g007
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cells observed within B cell follicles. Ongoing studies are aimed at determining the cell types in
the dLN with which monocytes and neutrophils interact, and how their localization deter-
mines the subsequent disruption of dLN architecture following infection.
We previously observed that pathogenic CHIKV infection blunts the accumulation of lym-
phocytes in the dLN by impairing recruitment of naïve lymphocytes from the circulation [23].
Failure to recruit new lymphocytes was due to reduced function of high endothelial venules
(HEVs) and decreased production of homeostatic chemokines. Preventing the early influx of
monocytes and neutrophils into the dLN restored naïve lymphocyte recruitment, as the lym-
phocyte numbers in the dLN were uniformly increased. Moreover, preventing the influx of
monocytes and neutrophils into the dLN improved organization of B cell follicles, the T cell
area, and the B-T cell border. It remains to be determined whether these infiltrating myeloid
cells directly also affect the function of HEVs or the production of homeostatic chemokines.
Furthermore, monocyte and neutrophil depletion improved virus-specific B cell responses in
Fig 8. An IRF5-dependent pathway is activated locally in the dLN. WT, Irf3-/-Irf7-/-, or Irf3-/-Irf5-/-Irf7-/- mice were inoculated with PBS (mock) or 103 PFU of
CHIKV AF15561 in the left footpad. At 24 hpi, the inoculated foot and the dLN were collected. qRT-PCR was used to analyze mRNA expression of (A) Ccl2, (B)
Cxcl10, (C) Ifng, (D) Il6, (E) Ifit1, and (F) Rsad2. Error bars represent mean ± SEM. Data (8–9 mice per group) are combined from 2 independent experiments.
Statistical significance was determined by one-way ANOVA with Tukey’s multiple comparisons test. ��P< 0.01, ���P< 0.001.
https://doi.org/10.1371/journal.ppat.1008292.g008
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the dLN, with more GC B cells and plasma cells generated. This improved GC formation is
likely a downstream consequence of boosted lymphocyte numbers and less perturbed dLN
organization earlier during infection.
Type I IFNs can promote monocyte recruitment during inflammatory responses [5, 50].
Our data reveal distinct roles for IFNAR1, MyD88, and IL-1R in the recruitment of monocytes
and neutrophils to the dLN. Neutrophil recruitment was inhibited by IFNAR1 signaling, but
required IL-1R-MyD88 signaling. These findings agree with prior reports demonstrating IL-
1R-dependent neutrophil recruitment in response to several inflammatory stimuli [51–53],
and a single report showing IFNAR1-mediated inhibition of neutrophil recruitment to
inflamed lungs following influenza A virus infection [54]. In contrast to neutrophils, monocyte
recruitment to the dLN following pathogenic CHIKV infection was independent of IFNAR1
and IL-1R signaling. However, the percentage and number of monocytes in the dLN was
reduced in MyD88-deficient mice, indicating that one or more TLRs likely drive monocyte
recruitment.
Total lymphocyte numbers in the dLN were increased in the dLN of Nos2-/- and Nox2-/-
mice compared with WT mice following pathogenic CHIKV infection. In addition, and in
contrast to WT mice, pathogenic CHIKV infection had minimal effects on the organization of
B cell follicles and the T cell zone in the dLN of Nos2-/- and Nox2-/- mice. Flow cytometric anal-
ysis revealed that monocytes, but not neutrophils, upregulated iNOS expression following
entry into the dLN. During LCMV infection of mice, monocytes infiltrating the dLN induced
apoptosis in virus-specific and bystander B cells in a Nos2-dependent manner [5]. Studies with
LCMV also observed B cell depletion in lymphoid tissue, however, individual roles for Nos2
[55] or Gr-1+ cells [56] were not defined. In contrast to LCMV infection, extensive lymphocyte
death or an increase in apoptotic lymphocytes does not occur in the dLN following pathogenic
CHIKV infection [23], suggesting that the infiltrating monocytes do not impair B cell
responses by inducing death of lymphocytes. Additionally, lymphocyte numbers were restored
only partially in mice deficient for Nos2 or Nox2, suggesting that the combined action of Nos2
and Nox2 or other monocyte and/or neutrophil-derived factors contribute to the impairment
of naive lymphocyte accumulation and disruption of LN organization. Depletion of either neu-
trophils or monocytes alone did not restore total lymphocyte numbers in the dLN, indicating
that influx of either cell type is sufficient to prevent accumulation of naïve lymphocytes.
Although the improved dLN organization and lymphocyte accumulation observed in Nos2-
deficient mice could be ascribed to lack of iNOS expression uniquely in monocytes, the mech-
anism(s) by which neutrophils impair lymphocyte accumulation and disrupt dLN architecture
remain to be determined.
Type I IFN signaling can modulate monocyte activation and differentiation, with context-
dependent pro-inflammatory or anti-inflammatory effects [36, 54, 57, 58]. Although not
required for recruitment of monocytes to the dLN after pathogenic CHIKV infection, type I
IFN signaling drives iNOS expression in monocytes following entry into the dLN. Further-
more, IRF5, but not IRF3 or IRF7, was responsible for induction of iNOS. IRF3 or IRF7 are
required for protection from fatal CHIKV infection, with systemic type I IFN production
being driven by the IRF7 response [37, 38]. However, the contribution of type I IFN signaling
and additional IRFs in other aspects of alphavirus pathogenesis remains poorly defined. Our
work suggests that an IRF5-dependent pathway acts locally in draining lymphoid tissue follow-
ing infection with CHIKV, whereas IRF3/7-dependent pathways are activated at the site of
inoculation. Studies in IRF5-overexpressing cells found that IRF5 induces a distinct subset of
IFNα genes compared with other IRFs, such as IRF7 [59]. In addition to IFNα, IRF5 also pro-
motes the transcription of genes encoding proinflammatory cytokines, such as Il12b, Tnfa,
and Il6 [41] and several chemokines [60]. Similar to our observations, IRF5 promotes the
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induction of several proinflammatory cytokines and chemokines, as well as recruitment and
activation of lymphocytes in the dLN following West Nile Virus (WNV) infection of mice
[61]. However, these IRF5-dependent responses were ultimately protective by limiting viral
spread and promoting optimal B cell immunity. In contrast, our data suggest that pathogenic
strains of CHIKV trigger an IRF5-dependent inflammatory pathway in the dLN that activates
infiltrating monocytes and neutrophils, ultimately causing disruption of dLN architecture and
decreased virus-specific B cell responses.
IRF5 is expressed constitutively in pDCs, classical or conventional DCs (cDCs), M1 macro-
phages, and B cells, with further upregulation following activation [41, 59, 62–65]. Upon acti-
vation with TLR ligands, IRF5 expression also can be induced in human monocytes,
neutrophils, and macrophages [41, 62, 66]. Thus, many immune cell types can express IRF5,
either constitutively or upon activation. Viral infections or agonists of TLR7 or TLR9 can acti-
vate IRF5 in DCs in vitro in a MyD88-dependent manner [39–41]. Following pathogenic
CHIKV infection, we observed a partial role for TLR7 in iNOS upregulation, suggesting that
recognition of endosomal viral RNA contributes to monocyte activation. However, our data
suggest role(s) for other MyD88-dependent TLR(s) in activating IRF5 to promote iNOS
expression in infiltrating monocytes. One or more of these TLRs may be activated by endoge-
nous damage-associated molecular patterns (DAMPs) released from damaged or dying cells
during the early stages of CHIKV infection, either at the site of inoculation or in the dLN. The
cell-intrinsic requirements for TLR(s), IRF5, and IFNAR1 expression in dLN monocyte iNOS
upregulation during CHIKV infection remain to be determined through the use of conditional
knockout mice.
In summary, we found that a rapid influx of Ly6Chi monocytes and neutrophils to the dLN
impairs lymphocyte accumulation, dLN organization, and downstream antiviral B cell
responses to pathogenic CHIKV infection in a manner partially dependent on Nos2 and
Nox2. Furthermore, we identified a role for MyD88-dependent IRF5-driven type I IFN signal-
ing in the dLN that promotes iNOS expression in infiltrating monocytes. Our findings reveal
an additional mechanism that dampens the development of the anti-CHIKV Ab response dur-
ing pathogenic CHIKV infection, and underscore how local innate immune responses in
draining lymphoid tissue dictate the magnitude of downstream adaptive immunity.
Materials and methods
Ethics
This study was conducted in accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals and the AVMA Guidelines for the Euthanasia of Animals. All
animal experiments were performed with the approval of the Institutional Animal Care and
Use Committee at the University School of Medicine (Assurance Number: A3269-01) or at the
Washington University School of Medicine (Assurance Number A3381-01). Experimental ani-
mals were humanely euthanized at defined endpoints by exposure to isoflurane vapors fol-
lowed by thoracotomy.
Mouse experiments
WT C57BL/6 (000664), Nos2-/- (002609; B6.129P2-Nos2tm1Lau), gp91phox-/- (002365;
B6.129S6-Cybbtm1Din), Tlr7-/- (008380; B6.129S1-Tlr7tm1Flv), Myd88-/- (009088; B6.129P2(SJL)-
Myd88tm1.1Defr), and LT-/- (002258; B6.129S2-Ltatm1Dch/J) mice were obtained from The Jack-
son Laboratory. Irf5-/- mice were a gift of T. Taniguchi (Tokyo, Japan), obtained from I. Rifkin
(Boston, MA), and were backcrossed for eight generations. After detection of a homozygous
Dock2 mutation in this line, it was backcrossed for five additional generations to obtain Irf5-/-
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Dock2wt/wt mice [61]. Irf3-/-Irf5-/-Irf7-/- mice were a gift from Dr. Sujan Shresta (La Jolla Insti-
tute for Immunology) and originally generated at Washington University [45]. Nos2-/-, gp91phox-/-
(Nox2-/-), Tlr7-/-, Myd88-/-, Irf5-/-, Irf3-/-Irf7-/-, Irf3-/-Irf5-/-Irf7-/-, and Ifnar1-/- mice were bred and
housed at the University of Colorado School of Medicine or Washington University under spe-
cific pathogen-free conditions. Mice were used at 3–4 weeks of age. Virus inoculations were per-
formed under isoflurane anaesthesia and all efforts were made to minimize animal suffering. All
mouse experiments were performed in an animal biosafety level 3 laboratory.
Mice were anesthetized with isoflurane and inoculated with 103 PFU of CHIKV subcutane-
ously in the left rear footpad in a volume of 10 μL of PBS/1% FBS. Mice were sacrificed after
exposure to isoflurane vapors followed by thoracotomy and perfusion with PBS at the indi-
cated time points. In some experiments, mice were treated with 300–500 μg of IgG2b isotype
control Ab (LTF-2), anti-Gr-1 mAb (RB6-8C5), IgG2a isotype control Ab (2A3), or anti-Ly-
6G mAb (1A8) (all from BioXCell) i.p. the day prior to infection. For IL-1R blockade, mice
were treated with 200 μg Armenian hamster IgG control Ab or anti-IL-1R Ab (JAMA-147)
(both from BioXCell) at the time of infection.
Cell lines and viruses
BHK-21 cells (American Type Culture Collection) were cultured at 37˚C in Minimum Essen-
tial Medium Alpha (MEMα) supplemented with 10% fetal bovine serum (FBS) and 10% tryp-
tose phosphate broth (TPB). Vero cells (American Type Culture Collection) were cultured at
37˚C in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) with 10%
FBS.
CHIKV cDNA clones encoding 181/25 and AF15561 have been described previously [67].
Stocks of infectious CHIKV strains were generated from cDNA clones and titered by plaque
assay on BHK-21 cells as previously described [68]. The number of particles/mL of each virus
stock was determined by qRT-PCR. All experiments were performed under biosafety level 3
conditions.
Isolation of cells from lymphoid tissue and flow cytometry
The left popliteal LN was gently homogenized in a Biomasher II tissue homogenizer (Kimble-
Chase) in RPMI 1640 (HyClone) supplemented with 10% FBS. For flow cytometric analysis of
infiltrating footpad or dLN cells, 2.5 mg/ml collagenase type I (Worthington Biochemical) and
17 μg/ml DNase I (Roche) were added to RPMI 1640 with 10% FBS, and samples were incu-
bated for 1 h at 37˚C with shaking (130 rpm). Following erythrocyte lysis (footpad only), cells
were passed through a 100 μm cell strainer (BD Falcon) and total viable cells were determined
by trypan blue exclusion. For analysis of circulating immune cells, blood was collected from
the inferior vena cava into 50 μL heparin. Following erythrocyte lysis, cells were stained as
below.
Single cell suspensions were incubated with anti-mouse FcγRIII/II (2.4G2; BD Pharmin-
gen) for 20 min on ice and then stained with antibodies against the following cell surface
markers in 1X PBS/2% FBS for 1 h on ice: CD45 (30-F11), CD11b (M1/70), Ly-6C (HK1.4),
Ly-6G (1A8), CD19 (6D5), B220 (RA3-6B2), TCRβ (H57-597), CD4 (RM4-5), CD8 (53–6.7),
CD95 (Fas; 15A7), GL7 (GL7), IgD (11-26c.2a), and CD138 (281–2) (all Abs from BioLegend,
BD Bioscience, or Thermo Fisher). Cells were washed three times in PBS/2% FBS and fixed
overnight in 1X PBS/1% PFA prior to analysis. For intracellular analysis of iNOS expression,
cells were stained first with antibodies against cell surface markers, fixed for 15 min at RT in
PBS/1% paraformaldehyde (PFA)/0.1% saponin, and then stained with anti-iNOS Ab (clone
CXNFT; Thermo Fisher) in PBS/2% FBS/0.1% saponin for 1 h at 4˚C. Cells were washed three
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times in PBS/2% FBS/0.1% saponin, fixed overnight in 1X PBS/1% PFA, and analyzed on a BD
LSR Fortessa cytometer using FACSDiva software. Further analysis was performed using
FlowJo software (Tree Star).
CHIKV ELISA and focus reduction neutralization test (FRNT)
CHIKV-specific antibodies in mouse sera were measured using a virion-based ELISA as
described [14]. Endpoint titers were defined as the reciprocal of the last dilution to have an
absorbance two times greater than background. Blank wells receiving no serum were used to
quantify background signal. Fold change was calculated by dividing the IgG endpoint of each
sample by the average IgG endpoint of the group receiving IgG2b control mAb.
For FRNT assays, Vero cells were seeded in 96-well plates. Serum samples were heat-inacti-
vated and serially diluted in DMEM/F12 medium with 2% FBS in 96-well plates. Approxi-
mately 100 focus-forming units (FFU) of virus stock was added to each well and the serum
plus virus mixture was incubated for 1 h at 37˚C. At the end of 1 h, medium was removed
from Vero cells and serum sample + virus mixture was added for 2 h at 37˚C. After 2 h, sample
was removed and cells were overlaid with 0.5% methylcellulose in MEM/5% FBS and incu-
bated 18 h at 37˚C. Cells were fixed with 1% PFA and probed with 500 ng/mL of the anti-
CHK-11 mAb [12] diluted in 1X PBS/0.1% saponin/0.1% bovine serum albumin (BSA) for 2 h
at RT. After washing, cells were incubated with horseradish peroxidase (HRP)-conjugated
goat anti-mouse IgG (Southern Biotech, 1:2000) for 1.5–2 h at RT. After washing, CHIKV-pos-
itive foci were visualized with TrueBlue substrate (Fisher) and counted using a CTL Biospot
analyzer and Biospot software (Cellular Technology). Percent infectivity was calculated com-
pared to a virus only (no serum) control. The FRNT50 value was defined as the reciprocal of
the last dilution to exhibit 50% infectivity. Fold change was calculated by dividing the FRNT50
of each sample by the average FRNT50 of the group receiving IgG2b control Ab.
CHIKV IgG enzyme linked immunosorbent assay (ELISPOT)
For quantification of CHIKV-specific IgG+ ASCs, dLNs were removed and processed into a
single cell suspension as above. Two-fold dilutions of cells (starting at 1 x 105) were plated on
filter plates (EMP Millipore MultiScreen HTS-IP) coated with 108 particles/well of CHIKV
AF15561 and incubated for 5 h at 37˚C. Biotin-conjugated anti-IgG and streptavidin-conju-
gated horseradish peroxidase (HRP) (both from Southern Biotech) were used for detection.
For development, 200 μL 3-amino-9-ethylcarbazole (AEC) solution (Sigma) was added to 9 ml
0.1 M sodium acetate buffer containing 4 μL 30% H2O2. Spots were analyzed on a C.T.L. ELI-
SPOT Reader using ImmunoSpot 6.1 software (Cellular Technology).
Gene expression analysis from the dLN and foot
The dLN or left foot was dissected and homogenized in TRIzol Reagent (Life Technologies)
for RNA analysis with a MagNA Lyser (Roche). RNA was isolated using the PureLink RNA
Mini kit (Thermo Fisher) with on-column DNase treatment. Gene expression was quantified
by RT-qPCR using available Taqman gene expression assays (Thermo Fisher). Expression of
each gene was normalized to 18S and expressed as fold change over mock samples.
Viral RNA analysis
Ankle and spleen tissues were dissected and homogenized in TRIzol Reagent (Life Technolo-
gies) for RNA analysis with a MagNA Lyser (Roche). Viral RNA in tissues was quantified by
RT-qPCR as previously described [23].
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Immunofluorescence and confocal microscopy
Lymph nodes were fixed in 1 mL of phosphate buffer containing 0.1 M L-lysine, 2% PFA, and
2.1 mg/mL NaIO4 at pH 7.4 for 24 h at 4˚C, followed by incubation in 30% sucrose phosphate-
buffered solution for 48 h, then in 30% sucrose/PBS for 24 hr. LNs were then embedded in
optimal-cutting-temperature medium (Electron Microscopy Sciences) and frozen in dry-ice-
cooled isopentane. Eighteen-μm sections were cut on a Leica cryostat (Leica Microsystems).
Sections were blocked with 5% goat, donkey, bovine, rat or rabbit serum and then stained with
one or more of the following: B220 (clone RA3-6B2, ThermoFisher), CD8α (clone 53–6.7,
ThermoFisher), ERTR-7 (Rat monoclonal, BioXCell), Gr-1 (clone RB6-8C5, BioXCell), and
GL7 (clone GL7, BioLegend). Images were acquired using identical photomultiplier tube
(PMT) and laser power settings on a Leica SP5 confocal equipped with HyD detectors (Leica).
Confocal microscopy images were performed of the entire popliteal lymph node (representing
approximately a 7 mm2 imaged area) and individual fields (tiles) were merged into a single
image file. Images were analysed using Imaris v9.02 software (Bitplane). The total number of
GCs, area per GC, and total GC area were calculated per 18-μM dLN section automatically
using Imaris’ surfaces function based upon GL7 staining. The total GC number was also con-
firmed manually.
Quantification and statistical analysis
Statistical details for each experiment are found in the corresponding figure legends. Statistical
analyses were conducted using GraphPad Prism 6.0.
Supporting information
S1 Fig. Peripheral lymph organs are required for clearance of CHIKV 181/25 infection in
joint-associated tissue. WT or congenic lymphotoxin alpha-deficient (LT-/-) C57BL/6 mice
were inoculated with 103 PFU of CHIKV 181/25 or AF15561 in the left footpad. At 28 dpi,
RNA was extracted from the (A) right ankle and (B) spleen and viral loads were determined
by RT-qPCR. Data are from one independent experiment.
(TIF)
S2 Fig. Circulating myeloid cells elicited by pathogenic CHIKV infection infiltrate the
dLN before the site of inoculation. C57BL/6 mice were inoculated with PBS (mock) or with
103 PFU of CHIKV 181/25 or AF15561 in the left footpad. At 24 hpi, the blood and left foot
were analyzed by flow cytometry. (A) Representative flow cytometry plots and percentages of
(B) CD11b+Ly6Chi monocytes or (C) CD11bhiLy6C+Ly6G+ neutrophils in the blood. (D) Rep-
resentative flow cytometry plots and numbers of (E) monocytes or (F) neutrophils in the left
foot. Data are combined from two (A-C) or five (D-F) independent experiments (n = 4–21 per
group). Statistical significance was determined by one-way ANOVA with Tukey’s post-test
(���, P< 0.001).
(TIF)
S3 Fig. Anti-Gr-1 mAb treatment does not affect lymphocyte accumulation in dLN follow-
ing attenuated CHIKV infection. C57BL/6 mice were treated with 500 μg of IgG2b isotype
control mAb or anti-Gr-1 mAb via intraperitoneal injection one day prior to inoculation with
103 PFU of CHIKV 181/25 in the left footpad. At 5 dpi, total cells in the dLN were enumerated.
Data are combined from 2 independent experiments.
(TIF)
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S4 Fig. The effects of anti-Gr-1 mAb treatment are largely confined to the dLN. C57BL/6
mice were treated with 300–500 μg IgG2b isotype control mAb or anti-Gr-1 mAb i.p. one day
prior to inoculation with 103 PFU of CHIKV AF15561 in the left footpad. (A) Representative
flow cytometry plots of GL7+CD95+ GC B cells (gated on CD19+B220+ cells), (B) percentage
and (C) total number of GC B cells in the left inguinal LN at 14 dpi. (D) Representative flow
cytometry plots of CD138+IgD- plasma cells (gated on CD19+), (E) percentage and (F) total
number of plasma cells in the left inguinal LN at 14 dpi. (G) Representative flow cytometry
plots of GL7+CD95+ GC B cells (gated on CD19+B220+ cells), (H) percentage and (I) total
number of GC B cells in the spleen at 14 dpi. (J) Representative flow cytometry plots of
CD138+IgD- plasma cells (gated on CD19+), (K) percentage and (L) total number of plasma
cells in the spleen at 14 dpi. Errors bars represent mean ± SEM. Data are derived from 2 inde-
pendent experiments. Statistical significance was determined by Student’s t-test. �P< 0.05,
��P< 0.01.
(TIF)
S5 Fig. iNOS expression in monocytes is independent of TRIF. C57BL/6 mice were inocu-
lated with PBS (mock) or with 103 PFU of CHIKV AF15561 in the left footpad and the dLN
was analyzed at 24 hpi. (A) Percentage and (B) representative flow cytometry plots of
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